Merck KGaA Finds R&D Nuggets: Plans Further Atacicept Studies In Lupus
This article was originally published in The Pink Sheet Daily
Executive Summary
A discussion with internal and external experts restarts clinical development of atacicept for lupus after a two-year hiatus.